Throughout the last three months, 5 analysts have evaluated ResMed (NYSE:RMD), offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ...

In the latest quarter, 5 analysts provided ratings for ResMed (NYSE:RMD), showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing ...

Across the recent three months, 9 analysts have shared their insights on ResMed (NYSE:RMD), expressing a variety of opinions spanning from bullish to bearish. The table below offers a condensed view ...

Across the recent three months, 7 analysts have shared their insights on ResMed (NYSE:RMD), expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates their ...

Resmed Inc ((RMD)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...